Plasmodium vivax HAP2/GCS1 gene exhibits limited genetic diversity among parasite isolates from the Greater Mekong Subregion.
Genetic diversity
HAP2/GCS1
Plasmodium vivax
Transmission-blocking vaccine
Journal
Parasites & vectors
ISSN: 1756-3305
Titre abrégé: Parasit Vectors
Pays: England
ID NLM: 101462774
Informations de publication
Date de publication:
07 Apr 2020
07 Apr 2020
Historique:
received:
21
11
2019
accepted:
28
03
2020
entrez:
9
4
2020
pubmed:
9
4
2020
medline:
25
11
2020
Statut:
epublish
Résumé
Antigens expressed in sexual stages of the malaria parasites are targets of transmission-blocking vaccines (TBVs). HAP2/GCS1, a TBV candidate, is critical for fertilization in Plasmodium. Here, the genetic diversity of PvHAP2 was studied in Plasmodium vivax parasite populations from the Greater Mekong Subregion (GMS). Plasmodium vivax clinical isolates were collected in clinics from the China-Myanmar border region (135 samples), western Thailand (41 samples) and western Myanmar (51 samples). Near full-length Pvhap2 (nucleotides 13-2574) was amplified and sequenced from these isolates. Molecular evolution studies were conducted to evaluate the genetic diversity, selection and population differentiation. Sequencing of the pvhap2 gene for a total of 227 samples from the three P. vivax populations revealed limited genetic diversity of this gene in the GMS (π = 0.00036 ± 0.00003), with the highest π value observed in Myanmar (0.00053 ± 0.00009). Y133S was the dominant mutation in the China-Myanmar border (99.26%), Myanmar (100%) and Thailand (95.12%). Results of all neutrality tests were negative for all the three populations, suggesting the possible action of purifying selection. Codon-based tests identified specific codons which are under purifying or positive selections. Wright's fixation index showed low to moderate genetic differentiation of P. vivax populations in the GMS, with F The present study showed a very low level of genetic diversity of pvhap2 gene among P. vivax populations in the Greater Mekong Subregion. The relative conservation of pvhap2 supports further evaluation of a Pvhap2-based TBV.
Sections du résumé
BACKGROUND
BACKGROUND
Antigens expressed in sexual stages of the malaria parasites are targets of transmission-blocking vaccines (TBVs). HAP2/GCS1, a TBV candidate, is critical for fertilization in Plasmodium. Here, the genetic diversity of PvHAP2 was studied in Plasmodium vivax parasite populations from the Greater Mekong Subregion (GMS).
METHODS
METHODS
Plasmodium vivax clinical isolates were collected in clinics from the China-Myanmar border region (135 samples), western Thailand (41 samples) and western Myanmar (51 samples). Near full-length Pvhap2 (nucleotides 13-2574) was amplified and sequenced from these isolates. Molecular evolution studies were conducted to evaluate the genetic diversity, selection and population differentiation.
RESULTS
RESULTS
Sequencing of the pvhap2 gene for a total of 227 samples from the three P. vivax populations revealed limited genetic diversity of this gene in the GMS (π = 0.00036 ± 0.00003), with the highest π value observed in Myanmar (0.00053 ± 0.00009). Y133S was the dominant mutation in the China-Myanmar border (99.26%), Myanmar (100%) and Thailand (95.12%). Results of all neutrality tests were negative for all the three populations, suggesting the possible action of purifying selection. Codon-based tests identified specific codons which are under purifying or positive selections. Wright's fixation index showed low to moderate genetic differentiation of P. vivax populations in the GMS, with F
CONCLUSIONS
CONCLUSIONS
The present study showed a very low level of genetic diversity of pvhap2 gene among P. vivax populations in the Greater Mekong Subregion. The relative conservation of pvhap2 supports further evaluation of a Pvhap2-based TBV.
Identifiants
pubmed: 32264948
doi: 10.1186/s13071-020-04050-0
pii: 10.1186/s13071-020-04050-0
pmc: PMC7137254
doi:
Substances chimiques
Antigens, Protozoan
0
DNA, Protozoan
0
Protozoan Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
175Subventions
Organisme : NIAID NIH HHS
ID : U19 AI089672
Pays : United States
Organisme : National Institute of Allergy and Infectious Diseases
ID : U19AI089672
Références
Mol Biol Evol. 2018 Jun 1;35(6):1547-1549
pubmed: 29722887
Adv Parasitol. 2015 Jun;89:109-52
pubmed: 26003037
J Travel Med. 2019 Jun 1;26(4):
pubmed: 30995310
Bioinformatics. 2010 Oct 1;26(19):2455-7
pubmed: 20671151
Mol Biol Evol. 2005 May;22(5):1208-22
pubmed: 15703242
PLoS Negl Trop Dis. 2015 Apr 16;9(4):e0003575
pubmed: 25880767
Mol Ecol Resour. 2010 May;10(3):564-7
pubmed: 21565059
Genetics. 1989 Nov;123(3):585-95
pubmed: 2513255
Mol Ecol. 2002 Feb;11(2):155-65
pubmed: 11856418
Genetics. 1993 Mar;133(3):693-709
pubmed: 8454210
Mol Biol Evol. 2017 Dec 1;34(12):3299-3302
pubmed: 29029172
Southeast Asian J Trop Med Public Health. 2013;44 Suppl 1:249-305; discussion 306-7
pubmed: 24159835
Lancet Infect Dis. 2019 Sep;19(9):943-951
pubmed: 31345709
J Med Invest. 2002 Aug;49(3-4):118-23
pubmed: 12323000
Acta Trop. 2010 Jun;114(3):157-61
pubmed: 19665985
Cell Rep. 2017 Dec 5;21(10):2868-2878
pubmed: 29212032
Mol Biol Evol. 1999 Jan;16(1):37-48
pubmed: 10331250
Curr Biol. 2017 Mar 6;27(5):651-660
pubmed: 28238660
Parasit Vectors. 2015 Dec 01;8:615
pubmed: 26627683
Nature. 1991 Jun 20;351(6328):652-4
pubmed: 1904993
Nat Protoc. 2015 Jun;10(6):845-58
pubmed: 25950237
Infect Immun. 2019 May 21;87(6):
pubmed: 30962400
Nat Cell Biol. 2006 Jan;8(1):64-71
pubmed: 16378100
Parasit Vectors. 2011 Nov 28;4:224
pubmed: 22117620
Proteins. 2006 Oct 1;65(1):40-8
pubmed: 16894596
Bioinformatics. 2015 Oct 15;31(20):3359-61
pubmed: 26069263
Sci Transl Med. 2009 Oct 14;1(2):2ra5
pubmed: 20165550
PLoS Genet. 2010 Mar 19;6(3):e1000882
pubmed: 20333238
Southeast Asian J Trop Med Public Health. 1999;30 Suppl 4:i-iv, 1-101
pubmed: 10935286
J Infect Dis. 2019 Apr 16;219(9):1499-1509
pubmed: 30500927
Cell. 2017 Feb 23;168(5):904-915.e10
pubmed: 28235200
Mol Biol Evol. 2013 May;30(5):1196-205
pubmed: 23420840
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10037-41
pubmed: 11517324
Malar J. 2016 Apr 12;15:202
pubmed: 27067024
Sci Rep. 2018 Oct 8;8(1):14902
pubmed: 30297725
Infect Genet Evol. 2016 Sep;43:50-7
pubmed: 27180894
Infect Immun. 2013 Dec;81(12):4377-82
pubmed: 24042109
Vaccine. 2009 Aug 20;27(38):5187-94
pubmed: 19596419
Development. 2006 Dec;133(23):4761-9
pubmed: 17079265
Genes Dev. 2008 Apr 15;22(8):1051-68
pubmed: 18367645
WHO South East Asia J Public Health. 2019 Apr;8(1):26-34
pubmed: 30950427
Vaccine. 2011 Jun 10;29(26):4308-15
pubmed: 21514344
Acta Trop. 2019 Oct;198:105104
pubmed: 31336059
Curr Opin Infect Dis. 2007 Oct;20(5):476-81
pubmed: 17762780
Nat Rev Microbiol. 2014 Dec;12(12):833-40
pubmed: 25329408
Cell. 2001 Jan 12;104(1):153-64
pubmed: 11163248
Cell Res. 2009 Feb;19(2):271-3
pubmed: 19153597